JAK2 and myeloproliferative disorder: Somatic mutations in JAK2 constitute a major diagnostic criterion for myeloproliferative neoplasms (MPN) and are found in approximately 95% of polycythemia vera cases and 50% of essential thrombocythemia and primary myelofibrosis [2,9,66,67].